Aurora Cannabis expects strong global cannabis revenue in Q1

The company provided outlook for Q1: “Expect continued strong global cannabis revenue driven by improved performance in Canadian medical, comparable performance in consumer, offset by temporary declines in some of our international markets. Taken together, global cannabis should be slightly lower compared to Q4 2025 and is expected to improve in later quarters due to increased distribution and further innovation. Seasonally higher revenues for plant propagation as they complete their peak quarter, in line with historical seasonal trends. Margins to hold strong and we expect positive adjusted EBITDA to continue, with a decline versus Q4 FY25 due to lower revenue contributions from the higher margin international markets. Free cash flow is projected to remain positive, due to continued strong performance and improved operating cash use.”